Urinary angiopoietin-2 is associated with albuminuria in patients with type 2 diabetes mellitus

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Chen, Shan ^a   Li, Huiqing ^a   Zhang, Chun ^a   Li, Zhenqiong ^a   Wang, Qiuyuan ^a   Guo, Jinting ^a   Luo, Changqing ^a   Wang, Yumei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; CREATININE; GLUCOSE; HEMOGLOBIN A1C; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY INJURY; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

EID: 84926324079     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/163120     Document Type: Article

References (42)

1. J. T. Lane, "Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective", American Journal of Physiology-Renal Physiology, vol. 286, no. 3, pp. F442-F450, 2004.
2. A. S. Woolf, L. Gnudi, and D. A. Long, "Roles of angiopoietins in kidney development and disease", Journal of the American Society of Nephrology, vol. 20, no. 2, pp. 239-244, 2009.
3. J. Karalliedde and G. Viberti, "Microalbuminuria and cardiovascular risk", The American Journal of Hypertension, vol. 17, no. 10, pp. 986-993, 2004.
4. A. Advani and R. E. Gilbert, "The endothelium in diabetic nephropathy", Seminars in Nephrology, vol. 32, no. 2, pp. 199-207, 2012.
5. F.-C. Chang, T.-S. Lai, C.-K. Chiang et al., "Angiopoietin-2 is associated with albuminuria and microinfammation in chronic kidney disease", PLoS ONE, vol. 8, no. 3, Article ID e54668, 2013.
6. T. Nakagawa, T. Kosugi, M. Haneda, C. J. Rivard, and D. A. Long, "Abnormal angiogenesis in diabetic nephropathy", Diabetes, vol. 58, no. 7, pp. 1471-1478, 2009.
7. R. Østerby, A. Hartmann, and H.-J. Bangstad, "Structural changes in renal arterioles in type I diabetic patients", Diabetologia, vol. 45, no. 4, pp. 542-549, 2002.
8. R. Østerby, J. Asplund, H.-J. Bangstad et al., "Neovascularization at the vascular pole region in diabetic glomerulopathy", Nephrology Dialysis Transplantation, vol. 14, no. 2, pp. 348-352, 1999.
9. Y. Kanesaki, D. Suzuki, G. Uehara et al., "Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy", The American Journal of Kidney Diseases, vol. 45, no. 2, pp. 288-294, 2005.
10. N. H. Kim, K. B. Kim, D. L. Kim et al., "Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in type 2 diabetes mellitus", Diabetic Medicine, vol. 21, no. 6, pp. 545-551, 2004.
11. H.-P. Hammes, J. Lin, P. Wagner et al., "Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy", Diabetes, vol. 53, no. 4, pp. 1104-1110, 2004.
12. P. C. Maisonpierre, C. Suri, P. F. Jones et al., "Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis", Science, vol. 277, no. 5322, pp. 55-60, 1997.
13. H. T. Yuan, E. V. Khankin, S. A. Karumanchi, and S. M. Parikh, "Angiopoietin 2 is a partial agonist/antagonist of tie2 signaling in the endothelium", Molecular and Cellular Biology, vol. 29, no. 8, pp. 2011-2022, 2009.
14. N. H. Kim, J. H. Oh, J. A. Seo et al., "Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy", Kidney International, vol. 67, no. 1, pp. 167-177, 2005.
15. M. E. Cooper, D. Vranes, S. Youssef et al., "Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes", Diabetes, vol. 48, no. 11, pp. 2229-2239, 1999.
16. S. L. Hoong, A. D. Blann, Y. C. Aun, B. Freestone, and G. Y. H. Lip, "Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention", Diabetes Care, vol. 27, no. 12, pp. 2918-2924, 2004.
17. A. Dei Cas and L. Gnudi, "VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment?" Metabolism: Clinical and Experimental, vol. 61, no. 12, pp. 1666-1673, 2012.
18. D. R. Cha, Y. S. Kang, S. Y. Han et al., "Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats", Journal of Endocrinology, vol. 183, no. 1, pp. 183-194, 2004.
19. P. Hovind, L. Tarnow, P. B. Oestergaard, and H.-H. Parving, "Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy", Kidney International, Supplement, vol. 57, no. 75, pp. S56-S61, 2000.
20. S. Rasul, M. H. Reiter, A. Ilhan, K. Lampichler, L. Wagner, and A. Kautzky-Willer, "Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study", Cardiovascular Diabetology, vol. 10, article 55, 2011.
21. P. Kümpers, S. David, M. Haubitz et al., "The Tie2 receptor antagonist angiopoietin 2 facilitates vascular infammation in systemic lupus erythematosus", Annals of the Rheumatic Diseases, vol. 68, no. 10, pp. 1638-1643, 2009.
22. B. Davis, A. Dei Cas, D. A. Long et al., "Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia", Journal of the American Society of Nephrology, vol. 18, no. 8, pp. 2320-2329, 2007.
23. G. C. Viberti, R. J. Jarrett, R. D. Hill, A. Argyropoulos, U. Mahmud, and H. Keen, "Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus", The Lancet, vol. 1, no. 8287, pp. 1430-1432, 1982.
24. K. G. Alberti and P. Z. Zimmet, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a who consultation", Diabetic Medicine, vol. 15, pp. 539-553, 1998.
25. "KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease", American Journal of Kidney Diseases, vol. 49, no. 2, supplement 2, pp. S12-S154, 2007.
26. B. Rizkalla, J. M. Forbes, Z. Cao, G. Boner, and M. E. Cooper, "Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the reninangiotensin system", Journal of Hypertension, vol. 23, no. 1, pp. 153-164, 2005.
27. S. David, S. G. John, H. J. Jefferies et al., "Angiopoietin-2 levels predict mortality in CKD patients", Nephrology, Dialysis, Trans plantation, vol. 27, no. 5, pp. 1867-1872, 2012.
28. R. C. Shroff, K. L. Price, M. Kolatsi-Joannou et al., "Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis", PLoS ONE, vol. 8, no. 2, Article ID e56273, 2013.
29. S. David, P. Kümpers, A. Lukasz et al., "Circulating angiopoietin-2 levels increase with progress of chronic kidney disease", Nephrology Dialysis Transplantation, vol. 25, no. 8, pp. 2571-2576, 2010.
30. S. H. Rudolfsson, A. Johansson, I. F. Lissbrant, P. Wikström, and A. Bergh, "Localized expression of angiopoietin 1 and 2 may explain unique characteristics of the rat testicular microvasculature", Biology of Reproduction, vol. 69, no. 4, pp. 1231-1237, 2003.
31. Y. Maeshima and H. Makino, "Angiogenesis and chronic kidney disease", Fibrogenesis & Tissue Repair, vol. 3, article 13, 2010.
32. S. Ogawa, K. Nako, M. Okamura et al., "A decline in glomerular filtration rate rather than renal arterial stenotic lesions, per se, predicts cardiovascular-renal events in type 2 diabetic patients", Circulation Journal, vol. 77, no. 11, pp. 2816-2822, 2013.
33. F.-C. Chang and S.-L. Lin, "The role of angiopoietin-2 in progressive renal fibrosis", Journal of the Formosan Medical Association, vol. 112, no. 4, pp. 175-176, 2013.
34. H. S. Lim, G. Y. H. Lip, and A. D. Blann, "Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis", Atherosclerosis, vol. 180, no. 1, pp. 113-118, 2005.
35. T. Okamoto, S.-I. Yamagishi, Y. Inagaki et al., "Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin", The FASEB Journal, vol. 16, no. 14, pp. 1928-1930, 2002.
36. S. C. Satchell, K. L. Anderson, and P. W. Mathieson, "Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties", Journal of the American Society of Nephrology, vol. 15, no. 3, pp. 566-574, 2004.
37. S. C. Satchell and P. W. Mathieson, "Angiopoietins: microvascular modulators with potential roles in glomerular pathophysiology", Journal of Nephrology, vol. 16, no. 2, pp. 168-178, 2003.
38. C. Dessapt-Baradez, A. S. Woolf, K. E. White et al., "Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease", Journal of the American Society of Nephrology, vol. 25, no. 1, pp. 33-42, 2014.
39. A. H. J. Salmon, C. R. Neal, L. M. Sage, C. A. Glass, S. J. Harper, and D. O. Bates, "Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx", Cardiovascular Research, vol. 83, no. 1, pp. 24-33, 2009.
40. T. Lenz, T. Haak, J. Malek, H.-J. Gröne, H. Geiger, and J. Gossmann, "Vascular endothelial growth factor in diabetic nephropathy", Kidney and Blood Pressure Research, vol. 26, no. 5-6, pp. 338-343, 2003.
41. K. Shimada, T. Baba, S. Neugebauer et al., "Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy", Journal of Diabetes and its Complications, vol. 16, no. 6, pp. 386-390, 2002.
42. A. D. Blann, F. M. Belgore, C. N. McCollum, S. Silverman, P. L. Lip, and G. Y. H. Lip, "Vascular endothelial growth factor and its receptor, Flt-I, in the plasma of patients with coronary or peripheral atherosclerosis, or type II diabetes", Clinical Science, vol. 102, no. 2, pp. 187-194, 2002.